Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease based » disease based (Expand Search)
mean decrease » a decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
Showing 61 - 80 results of 29,243 for search '(( significant decrease based ) OR ( significant ((mean decrease) OR (teer decrease)) ))', query time: 0.79s Refine Results
  1. 61
    Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI).

    Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). by Murat Tutar (22250461)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 62
    Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells.

    Spearman correlations between the age of the sample donor (20–70 years) and estimated proportions of neuronal, glial, and endothelial cells. by Arttu Autio-Kimura (20454681)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 63
    Trends in the observed total annual rainfall and mean temperature over Taita Taveta (1981–2020).

    Trends in the observed total annual rainfall and mean temperature over Taita Taveta (1981–2020). by Francis Kibagendi Nyambariga (16425739)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 64
    Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493).

    Bootstrapped spearman correlations from a randomly selected subset of male sample donor originating samples (n = 493). by Arttu Autio-Kimura (20454681)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 65
    Predicted banana distribution map (2016) using logistic regression model M2-12 fitted using 12 covariates and significant two-way combinations.

    Predicted banana distribution map (2016) using logistic regression model M2-12 fitted using 12 covariates and significant two-way combinations. by Dennis Ochola (11626912)

    Published 2022
    Save to List
    Saved in:
  6. 66
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 72
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 73
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 74
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 75
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 76
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 77
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 78
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 79
    Significant variables in decreasing importance for varietal clustering based on Random forest method.

    Significant variables in decreasing importance for varietal clustering based on Random forest method. by Wilfried Chevalier (10521466)

    Published 2021
    Save to List
    Saved in:
  20. 80
    Distribution of patients in the 4 age groups, mean value of IC-volume from both sides and separately for the left and right ICs.

    Distribution of patients in the 4 age groups, mean value of IC-volume from both sides and separately for the left and right ICs. by Pingling Kwok (14896191)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: